Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Amylmetacresol 290 microgram and dichlorobenzyl alcohol 580 microgram and lidocaine 780 microgram/actuation oromucosal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dichlorobenzyl alcohol (substance) |
Inferred relationship |
Some |
3 |
Amylmetacresol 290 microgram and dichlorobenzyl alcohol 580 microgram and lidocaine 780 microgram/actuation oromucosal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dichlorobenzyl alcohol (substance) |
Inferred relationship |
Some |
3 |
Product containing only amylmetacresol and dichlorobenzyl alcohol and lidocaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dichlorobenzyl alcohol (substance) |
Inferred relationship |
Some |
3 |
Product containing dichlorobenzyl alcohol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dichlorobenzyl alcohol (substance) |
Inferred relationship |
Some |
1 |
Amylmetacresol- and dichlorobenzyl alcohol- and lidocaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dichlorobenzyl alcohol (substance) |
Inferred relationship |
Some |
3 |
Product containing only amylmetacresol and dichlorobenzyl alcohol and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dichlorobenzyl alcohol (substance) |
Inferred relationship |
Some |
3 |
Product containing amylmetacresol and dichlorobenzyl alcohol and lidocaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dichlorobenzyl alcohol (substance) |
Inferred relationship |
Some |
3 |